major glp 1 drugs Comparing Ozempic, Wegovy and Other GLP-1 GLP-1 Receptor Agonist Shortage: Challenges
Description
Advertising or spam is also prohibited.
Pulses are our e-newsletters that look at recent trends and promising directions across life sciences
The study researchers relay that the possible anti-inflammatory effects likely stem from mechanisms of altering cytokine levels
Similarly the weight loss seen with Exenatide and some other early GLP-1 drugs was thought too limited to win approval for the treatment of obesity (Gilbert, Rosenthal, March 2024)
[1] The MHRA, NICE and NHS provide comprehensive guidance on the safe prescribing and monitoring of GLP-1 agonists, emphasising the importance of patient education regarding expected side effects and warning signs that warrant medical attention
doi:10.1111/dom.15624 142
